Simon D Brandt

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 36

Top Topics

High Resolution Mass Spectrometry

High Resolution

Top Venues

Drug testing and analysis

Journal of neurochemistry

bioRxiv : the preprint server for biology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ana Sofia Alberto-Silva, Selina Hemmer, Hailey A Bock, Leticia Alves da Silva, Kenneth R Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek, Elena Bossi, Thomas Stockner, Markus R Meyer, John D McCorvy, Simon D Brandt, Pierce V Kavanagh, Harald H Sitte
Bioisosteric analogs of MDMA: Improving the pharmacological profile? Journal of neurochemistry (2024)
Ana Sofia Alberto-Silva, Selina Hemmer, Hailey A Bock, Leticia Alves da Silva, Kenneth R Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek, Elena Bossi, Thomas Stockner, Markus R Meyer, John D McCorvy, Simon D Brandt, Pierce V Kavanagh, Harald H Sitte
Bioisosteric analogs of MDMA with improved pharmacological profile. bioRxiv : the preprint server for biology (2024)
Pierce V Kavanagh, Folker Westphal, Benedikt Pulver, Simon P Elliott, Alexander Stratford, Adam L Halberstadt, Simon D Brandt
Analytical and behavioral characterization of 1-dodecanoyl-LSD (1DD-LSD). Drug testing and analysis (2024)
Simon D Brandt, Pierce V Kavanagh, Sarah Gare, Alexander Stratford, Adam L Halberstadt
Analytical and behavioral characterization of 1-hexanoyl-LSD (1H-LSD). Drug testing and analysis (2024)
Ana Sofia Alberto-Silva, Selina Hemmer, Hailey A Bock, Leticia Alves da Silva, Kenneth R Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek, Elena Bossi, Thomas Stockner, Markus R Meyer, John D McCorvy, Simon D Brandt, Pierce V Kavanagh, Harald H Sitte
Bioisosteric analogs of MDMA: Improving the pharmacological profile? Journal of neurochemistry (2024)
Ana Sofia Alberto-Silva, Selina Hemmer, Hailey A Bock, Leticia Alves da Silva, Kenneth R Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek, Elena Bossi, Thomas Stockner, Markus R Meyer, John D McCorvy, Simon D Brandt, Pierce V Kavanagh, Harald H Sitte
Bioisosteric analogs of MDMA with improved pharmacological profile. bioRxiv : the preprint server for biology (2024)
Ana Sofia Alberto-Silva, Selina Hemmer, Hailey A Bock, Leticia Alves da Silva, Kenneth R Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek, Elena Bossi, Thomas Stockner, Markus R Meyer, John D McCorvy, Simon D Brandt, Pierce V Kavanagh, Harald H Sitte
Bioisosteric analogs of MDMA with improved pharmacological profile. bioRxiv : the preprint server for biology (2024)
Ana Sofia Alberto-Silva, Selina Hemmer, Hailey A Bock, Leticia Alves da Silva, Kenneth R Scott, Nina Kastner, Manan Bhatt, Marco Niello, Kathrin Jäntsch, Oliver Kudlacek, Elena Bossi, Thomas Stockner, Markus R Meyer, John D McCorvy, Simon D Brandt, Pierce V Kavanagh, Harald H Sitte
Bioisosteric analogs of MDMA: Improving the pharmacological profile? Journal of neurochemistry (2024)
Verena Angerer, Yasmin Schmid, Florian Franz, Heike Gnann, Jan Manuel Speer, Anke Gnann, Stephan Helmecke, Armin Buchwald, Simon D Brandt, Torsten Passie, Matthias E Liechti, Volker Auwärter
Acute psychotropic, autonomic, and endocrine effects of 5,6-methylenedioxy-2-aminoindane (MDAI) compared with 3,4-methylenedioxymethamphetamine (MDMA) in human volunteers: A self-administration study. Drug testing and analysis (2023)
Simon D Brandt, Pierce V Kavanagh, Folker Westphal, Benedikt Pulver, Hannes Max Schwelm, Alexander Stratford, Volker Auwärter, Adam L Halberstadt
Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N 6 -ethylnorlysergic acid N,N-diethylamide (ETH-LAD). Drug testing and analysis (2023)
Simon D Brandt, Michael Collins
Addressing the challenges in forensic drug chemistry II. Drug testing and analysis 14 (3) (2022)
Matthias J Richter, Lea Wagmann, Pierce V Kavanagh, Simon D Brandt, Markus R Meyer
In vitro metabolic fate of the synthetic cannabinoid receptor agonists (quinolin-8-yl 4-methyl-3-(morpholine-4-sulfonyl)benzoate [QMMSB]) and (quinolin-8-yl 4-methyl-3-((propan-2-yl)sulfamoyl)benzoate [QMiPSB]) including isozyme mapping and carboxylesterases activity testing. Drug testing and analysis (2022)
Simon D Brandt, Pierce V Kavanagh, Folker Westphal, Benedikt Pulver, Hannes Max Schwelm, Kyla Whitelock, Alexander Stratford, Volker Auwärter, Adam L Halberstadt
Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD. Drug testing and analysis 14 (8) (2022)
Pierce V Kavanagh, Folker Westphal, Benedikt Pulver, Hannes Max Schwelm, Alexander Stratford, Volker Auwärter, Stephen J Chapman, Adam L Halberstadt, Simon D Brandt
Analytical profile of the lysergamide 1cP-AL-LAD and detection of impurities. Drug testing and analysis (2022)
Thomas J F Angenoorth, Stevan Stankovic, Marco Niello, Marion Holy, Simon D Brandt, Harald H Sitte, Julian Maier
Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter. International journal of molecular sciences 22 (23) (2021)
Simon D Brandt, Pierce V Kavanagh, Folker Westphal, Alexander Stratford, Peter Blanckaert, Geraldine Dowling, Matthias Grill, Hannes Max Schwelm, Volker Auwärter, Stephen J Chapman
Separating the wheat from the chaff: Observations on the analysis of lysergamides LSD, MIPLA, and LAMPA. Drug testing and analysis (2021)
Simon D Brandt, Pierce V Kavanagh, Folker Westphal, Benedikt Pulver, Kathleen Morton, Alexander Stratford, Geraldine Dowling, Adam L Halberstadt
Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD). Drug testing and analysis (2021)
Simon D Brandt, Pierce V Kavanagh, Folker Westphal, Alexander Stratford, Simon P Elliott, Geraldine Dowling, Adam L Halberstadt
Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ). Drug testing and analysis 12 (10) (2020)
Christina Grumann, Kerstin Henkel, Simon D Brandt, Alexander Stratford, Torsten Passie, Volker Auwärter
Pharmacokinetics and subjective effects of 1P-LSD in humans after oral and intravenous administration. Drug testing and analysis 12 (8) (2020)
Simon D Brandt, Pierce V Kavanagh, Folker Westphal, Alexander Stratford, Anna U Odland, Adam K Klein, Geraldine Dowling, Nicola M Dempster, Jason Wallach, Torsten Passie, Adam L Halberstadt
Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD). Drug testing and analysis 12 (6) (2020)
Simon D Brandt, Laura Carlino, Pierce V Kavanagh, Folker Westphal, Wolfgang Dreiseitel, Geraldine Dowling, Michael H Baumann, Harald H Sitte, Adam L Halberstadt
Syntheses and analytical characterizations of novel (2-aminopropyl)benzo[b]thiophene (APBT) based stimulants. Drug testing and analysis 12 (8) (2020)
Simon D Brandt, Pierce V Kavanagh, Folker Westphal, Wolfgang Dreiseitel, Geraldine Dowling, Matthew J Bowden, James P B Williamson
Synthetic cannabinoid receptor agonists: Analytical profiles and development of QMPSB, QMMSB, QMPCB, 2F-QMPSB, QMiPSB, and SGT-233. Drug testing and analysis 13 (1) (2020)
Lea Wagmann, Nora Hempel, Lilian H J Richter, Simon D Brandt, Alexander Stratford, Markus R Meyer
Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings. Drug testing and analysis 11 (10) (2019)
Michael Dybek, Jason Wallach, Pierce V Kavanagh, Tristan Colestock, Nadine Filemban, Geraldine Dowling, Folker Westphal, Simon P Elliott, Adeboye Adejare, Simon D Brandt
Syntheses and analytical characterizations of the research chemical 1-[1-(2-fluorophenyl)-2-phenylethyl]pyrrolidine (fluorolintane) and five of its isomers. Drug testing and analysis 11 (8) (2019)
Simon D Brandt, Pierce V Kavanagh, Folker Westphal, Alexander Stratford, Simon P Elliott, Geraldine Dowling, Jason Wallach, Adam L Halberstadt
Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD). Drug testing and analysis 11 (8) (2019)
Lea Wagmann, Simon D Brandt, Alexander Stratford, Hans H Maurer, Markus R Meyer
Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases. Drug testing and analysis 11 (2) (2018)
Geraldine Dowling, Pierce V Kavanagh, Hans-Georg Eckhardt, Brendan Twamley, Gary Hessman, Gavin McLaughlin, John O'Brien, Simon D Brandt
An approach to shortening the timeframe between the emergence of new compounds on the drugs market and the availability of reference standards: The microscale syntheses of nitrazolam and clonazolam for use as reference materials, utilizing polymer-supported reagents. Drug testing and analysis (2018)
Gavin McLaughlin, Michael H Baumann, Pierce V Kavanagh, Noreen Morris, John D Power, Geraldine Dowling, Brendan Twamley, John O'Brien, Gary Hessman, Folker Westphal, Donna Walther, Simon D Brandt
Synthesis, analytical characterization, and monoamine transporter activity of the new psychoactive substance 4-methylphenmetrazine (4-MPM), with differentiation from its ortho- and meta- positional isomers. Drug testing and analysis 10 (9) (2018)
Achim T Caspar, Jonas B Gaab, Julian A Michely, Simon D Brandt, Markus R Meyer, Hans H Maurer
Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MSn , and LC-HR-MS/MS. Drug testing and analysis 10 (1) (2017)
Gavin McLaughlin, Noreen Morris, Pierce V Kavanagh, John D Power, Geraldine Dowling, Brendan Twamley, John O'Brien, Gary Hessman, Brian Murphy, Donna Walther, John S Partilla, Michael H Baumann, Simon D Brandt
Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo and (±)-erythro diastereomers. Drug testing and analysis 9 (3) (2017)
Simon D Brandt, Pierce V Kavanagh, Folker Westphal, Simon P Elliott, Jason Wallach, Alexander Stratford, David E Nichols, Adam L Halberstadt
Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD). Drug testing and analysis 9 (10) (2017)
Simon D Brandt, Pierce V Kavanagh, Brendan Twamley, Folker Westphal, Simon P Elliott, Jason Wallach, Alexander Stratford, Landon M Klein, John D McCorvy, David E Nichols, Adam L Halberstadt
Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775). Drug testing and analysis 10 (2) (2017)
Simon D Brandt, Pierce V Kavanagh
Addressing the challenges in forensic drug chemistry. Drug testing and analysis 9 (3) (2017)
John D Power, Pierce Kavanagh, Gavin McLaughlin, Michael Barry, Geraldine Dowling, Simon D Brandt
'APAAN in the neck' - A reflection on some novel impurities found in seized materials containing amphetamine in Ireland during routine forensic analysis. Drug testing and analysis 9 (7) (2017)
Tristan Colestock, Jason Wallach, Matt Mansi, Nadine Filemban, Hamilton Morris, Simon P Elliott, Folker Westphal, Simon D Brandt, Adeboye Adejare
Syntheses, analytical and pharmacological characterizations of the 'legal high' 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine (3-MeO-PCMo) and analogues. Drug testing and analysis 10 (2) (2017)
Kelly B Texter, Rachel Waymach, Pierce V Kavanagh, John E O'Brien, Brian Talbot, Simon D Brandt, Elizabeth A Gardner
Identification of pyrolysis products of the new psychoactive substance 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanone hydrochloride (bk-2C-B) and its iodo analogue bk-2C-I. Drug testing and analysis 10 (1) (2017)